CanSino's #COVID_19 #vaccine candidate approved for military use in China
![]() 2343 Monday, 29 June, 2020, 17:25 China's military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and somewhat efficient, the company said on Monday. The Ad5-nCoV is one of the eight vaccine candidates being developed by Chinese companies and researchers approved to be moved into human trials for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada. China’s Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year, CanSino said in a filing. The vaccine candidate was developed jointly by CanSino and the Beijing Institute of Biotechnology in the Academy of Military Medical Sciences. “The Ad5-nCoV is currently limited to military use only and its use cannot be expanded to a broader vaccination range without the approval of the Logistics Support Department,” CanSino said, referring to the Central Military Commission department where the military use of the vaccine was approved. |
Musk: "Armenia is the 130th country where Starlink is already available"
146128.03.2025, 09:51Elon Musk plans to create an "army" of Optimus humanoid robots
180625.03.2025, 12:09China’s commercial Mach-4 drone tipped to make first flight next year
911623.01.2025, 19:38'We're racing to launch': Exploration to soar under Trump and Musk, space firm boss says
852720.01.2025, 22:02China runs final tests of hypersonic air-to-air missile in extreme Mars mission tunnel
929319.01.2025, 20:24First Baby Born Using Technology That Matures Eggs Outside the Body
1184720.12.2024, 20:13SpaceX makes history as 'Mechazilla' successfully catches returning Starship booster (video)
1953913.10.2024, 21:30The impact of COVID-19 on the debate on open science: a qualitative analysis of published materials from the period of the pandemic
1918411.10.2024, 03:12